Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.
3.

Heart rate slowing versus other pharmacological antianginal strategies.

Diaz A, Tardif JC.

Adv Cardiol. 2006;43:65-78. Review.

PMID:
16936473
4.

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.

Tardif JC, Ponikowski P, Kahan T; ASSOCIATE Study Investigators.

Eur Heart J. 2009 Mar;30(5):540-8. doi: 10.1093/eurheartj/ehn571. Epub 2009 Jan 9.

6.
7.

Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.

Prasad UK, Gray D, Purcell H.

Adv Ther. 2009 Feb;26(2):127-37. doi: 10.1007/s12325-009-0005-x. Epub 2009 Mar 2. Review.

PMID:
19259630
8.

[Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].

Belousov IuB, Erofeeva SB, Maneshina OA.

Kardiologiia. 2006;46(8):36-48. Review. Russian.

PMID:
17047598
9.

Ivabradine: beyond heart rate control.

Riccioni G, Vitulano N, D'Orazio N.

Adv Ther. 2009 Jan;26(1):12-24. doi: 10.1007/s12325-008-0130-y. Epub 2009 Jan 22. Review.

PMID:
19165437
10.

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.

Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K; INITIATIVE Investigators.

Eur Heart J. 2005 Dec;26(23):2529-36. Epub 2005 Oct 7.

11.

Angina: Ivabradine for treatment of stable angina pectoris.

de Silva R, Fox KM.

Nat Rev Cardiol. 2009 May;6(5):329-30. doi: 10.1038/nrcardio.2009.47.

PMID:
19377492
12.

Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.

Borer JS, Fox K, Jaillon P, Lerebours G; Ivabradine Investigators Group.

Circulation. 2003 Feb 18;107(6):817-23.

13.

Ivabradine: new drug. Best avoided in stable angina.

[No authors listed]

Prescrire Int. 2007 Apr;16(88):53-6.

PMID:
17458043
14.

Ivabradine: a selective If current inhibitor in the treatment of stable angina.

Andrikopoulos G, Dasopoulou C, Sakellariou D, Tzeis S, Koulouris S, Kranidis A, Kappos K, Manolis AS.

Recent Pat Cardiovasc Drug Discov. 2006 Nov;1(3):277-82. Review.

PMID:
18221092
15.

[Possibilities of reducing heart rate by I(f)-channel inhibitors].

Hennersdorf MG.

Med Klin (Munich). 2006 Mar 22;101 Suppl 1:150-2. German.

PMID:
16802542
16.

Novel If current inhibitor ivabradine: safety considerations.

Savelieva I, Camm AJ.

Adv Cardiol. 2006;43:79-96. Review.

PMID:
16936474
17.

Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.

Borer JS, Le Heuzey JY.

Am J Ther. 2008 Sep-Oct;15(5):461-73. doi: 10.1097/MJT.0b013e3181758855. Review.

PMID:
18806523
18.

Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.

Tardif JC.

Drugs Today (Barc). 2008 Mar;44(3):171-81. doi: 10.1358/dot.2008.44.1193864. Review.

PMID:
18536779
19.

The funny current: cellular basis for the control of heart rate.

DiFrancesco D, Borer JS.

Drugs. 2007;67 Suppl 2:15-24. Review.

PMID:
17999560
20.

[Heart rate reduction as a therapeutic strategy: novel options].

Hoppe UC.

Internist (Berl). 2006 Dec;47(12):1289-93. German.

PMID:
17077980
Items per page

Supplemental Content

Write to the Help Desk